Skip to content

Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults

Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02496858
Acronym
GRAND
Enrollment
2000
Registered
2015-07-14
Start date
2017-05-12
Completion date
2022-05-31
Last updated
2019-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Percutaneous Coronary Intervention

Keywords

Young Patient, Genetic Characteristics

Brief summary

The aim of this study is to identify genetic loci,or gene variations contributing to the development of coronary artery disease (CAD) in Chinese young adults. Investigators will compare coronary angiogram results to genetic findings within young CAD patients.

Detailed description

During last 10 years, the rise in coronary artery disease (CAD) prevalence in Chinese young adults is observed and percutaneous coronary intervention (PCI) is generally considered to be low operative risk in these young patients. Genome-wide association studies have identified a considerable number of common genetic variants related to CAD. However, the extent to which these genetic variants are related to the future cardiovascular events, the prevalence, extent, severity, and prognosis of young patients with CAD is not clear. The aim of this study is to investigate the genetic loci, or gene variations contributing to the development and prognosis of CAD in Chinese young adult. Investigators will compare the angiogram results to genetic findings first in patients with different stages of CAD. Then, investigators will collect patients from hospital discharge registry, and compare long-term outcome as well as on operative details in different gene groups. The results of the study provide a possibility to develop a gene test to recognize patients at risk at its early stage, and needing for preventive medicine.

Interventions

None listed

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. premature CAD, includes patients who aged ≥ 18 and ≤ 45 years , and with at least one main coronary artery stenosis ≥ 50% confirmed by coronary angiography, involving left main coronary artery, left anterior descending branch, left circumflex branch or right coronary artery, and manifested as occult CAD, stable CAD, unstable angina pectoris, non-ST segment elevated myocardial infarction and ST segment elevated myocardial infarction; 2. mature CAD, refers to patients who aged ≥ 65 years and meat the same CAD diagnostic criteria as above; 3. age matched individuals who had coronary arteries without obvious stenosis.

Exclusion criteria

1. severely sick with limited life-expectancy \< 1 year; 2. patients with malignancies; 3. pregnant or planning for pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Number of cardiac death36 monthsAny death from cardiac conditions
Number of patients developing myocardial infarction36 monthsAny case of acute myocardial infarction which meet the Criteria according to current guidelines.
Number of patients developing stroke36 monthsAny events of ishcemic stroke, TIA or hemorrhagic stroke
Number of participants undergoing unscheduled repeat revascularization of target or non-target vessel36 monthsAny unshceduled percutaneous coronary intervention or coronary artery bypass grafting after primary revascularization

Secondary

MeasureTime frameDescription
Number of stent thrombosis, bleeding、non-cardiac death and all-cause death.36 monthsComposite of stent thrombosis, bleeding、non-cardiac death and all-cause death.

Countries

China

Contacts

Primary ContactKang Yao, M.D., Ph.D.
yao.kang@zs-hospital.sh.cn86+13818988550

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026